CZ20033112A3 - Naphtothiazine positive allosteric ampa receptor modulators (paarm) - Google Patents
Naphtothiazine positive allosteric ampa receptor modulators (paarm) Download PDFInfo
- Publication number
- CZ20033112A3 CZ20033112A3 CZ20033112A CZ20033112A CZ20033112A3 CZ 20033112 A3 CZ20033112 A3 CZ 20033112A3 CZ 20033112 A CZ20033112 A CZ 20033112A CZ 20033112 A CZ20033112 A CZ 20033112A CZ 20033112 A3 CZ20033112 A3 CZ 20033112A3
- Authority
- CZ
- Czechia
- Prior art keywords
- alkyl
- different
- halogen
- same
- halogen atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10123952A DE10123952A1 (de) | 2001-05-17 | 2001-05-17 | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20033112A3 true CZ20033112A3 (en) | 2004-03-17 |
Family
ID=7685080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20033112A CZ20033112A3 (en) | 2001-05-17 | 2002-05-15 | Naphtothiazine positive allosteric ampa receptor modulators (paarm) |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1404340A1 (no) |
| JP (1) | JP2004529980A (no) |
| KR (1) | KR20040007572A (no) |
| CN (1) | CN1533278A (no) |
| AR (1) | AR036332A1 (no) |
| BG (1) | BG108324A (no) |
| BR (1) | BR0209796A (no) |
| CA (1) | CA2449189A1 (no) |
| CO (1) | CO5550460A2 (no) |
| CZ (1) | CZ20033112A3 (no) |
| DE (1) | DE10123952A1 (no) |
| EA (1) | EA006608B1 (no) |
| EC (1) | ECSP034852A (no) |
| EE (1) | EE200300566A (no) |
| HR (1) | HRP20030933A2 (no) |
| HU (1) | HUP0401273A3 (no) |
| IL (1) | IL158642A0 (no) |
| MX (1) | MXPA03010373A (no) |
| NO (1) | NO20035088L (no) |
| NZ (1) | NZ530154A (no) |
| PL (1) | PL364053A1 (no) |
| SK (1) | SK14222003A3 (no) |
| UY (1) | UY27290A1 (no) |
| WO (1) | WO2002100411A1 (no) |
| YU (1) | YU90403A (no) |
| ZA (1) | ZA200308466B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009002180A (es) * | 2006-08-31 | 2009-06-05 | Univ Alberta | Metodo de inhibicion de la depresion respiratoria mediante el uso de moduladores alostericos positivos del receptor ampa. |
| CN111518058B (zh) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | 一种噁噻嗪类化合物及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| AU4711899A (en) * | 1998-06-25 | 2000-01-10 | Merck & Co., Inc. | Naphtho(1,8-de)thiasin-2-yl methyl carbapenem antibacterials |
| DE10004572A1 (de) * | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2001
- 2001-05-17 DE DE10123952A patent/DE10123952A1/de not_active Withdrawn
-
2002
- 2002-05-15 BR BR0209796-6A patent/BR0209796A/pt not_active Expired - Fee Related
- 2002-05-15 YU YU90403A patent/YU90403A/sh unknown
- 2002-05-15 CA CA002449189A patent/CA2449189A1/en not_active Abandoned
- 2002-05-15 EE EEP200300566A patent/EE200300566A/xx unknown
- 2002-05-15 KR KR10-2003-7014965A patent/KR20040007572A/ko not_active Application Discontinuation
- 2002-05-15 EP EP02750931A patent/EP1404340A1/en not_active Withdrawn
- 2002-05-15 EA EA200301167A patent/EA006608B1/ru not_active IP Right Cessation
- 2002-05-15 JP JP2003503232A patent/JP2004529980A/ja not_active Abandoned
- 2002-05-15 MX MXPA03010373A patent/MXPA03010373A/es unknown
- 2002-05-15 UY UY27290A patent/UY27290A1/es not_active Application Discontinuation
- 2002-05-15 HU HU0401273A patent/HUP0401273A3/hu unknown
- 2002-05-15 SK SK1422-2003A patent/SK14222003A3/sk unknown
- 2002-05-15 NZ NZ530154A patent/NZ530154A/en unknown
- 2002-05-15 WO PCT/EP2002/005338 patent/WO2002100411A1/en not_active Application Discontinuation
- 2002-05-15 CZ CZ20033112A patent/CZ20033112A3/cs unknown
- 2002-05-15 IL IL15864202A patent/IL158642A0/xx unknown
- 2002-05-15 PL PL02364053A patent/PL364053A1/xx not_active Application Discontinuation
- 2002-05-15 CN CNA028100832A patent/CN1533278A/zh active Pending
- 2002-05-17 AR ARP020101827A patent/AR036332A1/es not_active Suspension/Interruption
-
2003
- 2003-10-30 ZA ZA200308466A patent/ZA200308466B/en unknown
- 2003-11-07 BG BG108324A patent/BG108324A/bg active Pending
- 2003-11-14 NO NO20035088A patent/NO20035088L/no not_active Application Discontinuation
- 2003-11-14 HR HR20030933A patent/HRP20030933A2/xx not_active Application Discontinuation
- 2003-11-17 EC EC2003004852A patent/ECSP034852A/es unknown
- 2003-12-01 CO CO03105591A patent/CO5550460A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002100411A1 (en) | 2002-12-19 |
| KR20040007572A (ko) | 2004-01-24 |
| ECSP034852A (es) | 2003-12-24 |
| SK14222003A3 (sk) | 2004-05-04 |
| DE10123952A1 (de) | 2002-11-21 |
| EP1404340A1 (en) | 2004-04-07 |
| IL158642A0 (en) | 2004-05-12 |
| HRP20030933A2 (en) | 2004-04-30 |
| NO20035088D0 (no) | 2003-11-14 |
| NO20035088L (no) | 2003-11-14 |
| PL364053A1 (en) | 2004-12-13 |
| HUP0401273A3 (en) | 2006-11-28 |
| YU90403A (sh) | 2006-05-25 |
| BR0209796A (pt) | 2004-06-01 |
| MXPA03010373A (es) | 2004-03-16 |
| JP2004529980A (ja) | 2004-09-30 |
| CA2449189A1 (en) | 2002-12-19 |
| EA006608B1 (ru) | 2006-02-24 |
| EE200300566A (et) | 2004-02-16 |
| HUP0401273A2 (hu) | 2004-10-28 |
| ZA200308466B (en) | 2004-05-24 |
| NZ530154A (en) | 2005-09-30 |
| AR036332A1 (es) | 2004-09-01 |
| UY27290A1 (es) | 2002-12-31 |
| CN1533278A (zh) | 2004-09-29 |
| CO5550460A2 (es) | 2005-08-31 |
| EA200301167A1 (ru) | 2004-06-24 |
| BG108324A (bg) | 2004-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014114274A1 (zh) | 氘代的苯基氨基嘧啶化合物以及包含该化合物的药物组合物 | |
| CN102264733A (zh) | 新型多巴胺d3受体配体，其制备方法及其医药用途 | |
| BR112020023861A2 (pt) | Derivado de p-fenilenodiamina como regulador de canal de potássio e método de preparação e aplicação médica do mesmo | |
| JP4891510B2 (ja) | 新規な正のアロステリックａｍｐａ受容体モジュレーター（ｐａａｒｍ）、その製法及び医薬組成物としての使用 | |
| DK168010B1 (da) | Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse | |
| DK170890B1 (da) | 1,2,4,5-Tetrahydro-3H-3-benzazepinsulfonamid-forbindelser, deres anvendelse til fremstilling af antiarytmia-lægemidler og farmaceutiske præparater indeholdende sulfonamiderne samt 1,2,4,5-tetrahydro-3H-3-benzazepin-forbindelser, der er nyttige som mellemprodukter | |
| DK171821B1 (da) | 9-chlor-1,5-benzothiazepinderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse | |
| JP2010095550A (ja) | キノリン誘導体 | |
| CZ20033112A3 (en) | Naphtothiazine positive allosteric ampa receptor modulators (paarm) | |
| JP4826983B2 (ja) | シクロヘプタ［ｂ］ピリジン−３−カルボニルグアニジン誘導体およびそれを含有する医薬品 | |
| US7026475B2 (en) | Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions | |
| JP2022548859A (ja) | 認知機能の改善における使用および物質依存症に対する使用のためのチアゾールおよびジフェニル置換スルホキシド | |
| AU762526B2 (en) | Novel type condensed pyridazinone compounds | |
| WO2019082910A1 (ja) | バソプレシン受容体拮抗剤 | |
| KR19990021835A (ko) | 축합 벤조디아제피논 유도체 및 이의 의약 조성물 | |
| JPH04211666A (ja) | ４−フェニルフタラジン誘導体 | |
| AU2002345759A1 (en) | Naphtothiazine positive allosteric AMPA receptor modulators (PAARM) | |
| EP0668276A1 (en) | 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivative, process for producing the same, and use thereof | |
| JPH01156982A (ja) | チエノトリアゾロジアゼピン誘導体 | |
| HU203235B (en) | Process for producing new isoxazole derivatives | |
| JPH0676414B2 (ja) | ベンゼン縮合複素環化合物 | |
| JPH0873463A (ja) | ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途 |